5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV InfectionPre-Exposure Prophylaxis of HIV InfectionActive, not recruitingPhase 32026-10-06NCT04925752
A Clinical Study of the HCMV-TB Vaccine Candidate VIR-1778 in Healthy AdultsActinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosisNot yet recruitingPhase 12026-09-14NCT07818824
Attachment Inhibitor Comparison in Heavily Treatment Experienced PatientsBlood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted diseaseActive, not recruitingPhase 32026-08-21NCT02362503
FocaL Mass Drug Administration for Vivax Malaria EliminationInfections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne diseaseRecruitingPhase 32026-06-09NCT05690841
Therapeutics for Moderate and Severe DengueFlaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, dengue shock syndrome, hemorrhagic fever, vector-borne disease, viral hemorrhagic fever, viral infectious diseaseNot yet recruitingPhase 32026-04-21NCT07543458